Ausgabe 5/2016
Inhalt (12 Artikel)
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer
Alessandra Modena, Roberto Iacovelli, Aldo Scarpa, Matteo Brunelli, Chiara Ciccarese, Emanuela Fantinel, Davide Bimbatti, Francesco Massari, Guido Martignoni, Giampaolo Tortora
Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer
Hartmut Kristeleit, Marina Parton, Mark Beresford, Iain R. Macpherson, Rajan Sharma, Loren Lazarus, Muireann Kelleher
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?
Marco Puzzoni, Nicola Silvestris, Francesco Leone, Riccardo Giampieri, Luca Faloppi, Laura Demurtas, Emanuela Dell’Aquila, Donatella Marino, Oronzo Brunetti, Silvio Ken Garattini, Elena Ongaro, Giorgio Astara, Laura Orgiano, Giuseppe Aprile, Daniele Santini, Mario Scartozzi
Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment
Hiroki Ishihara, Tsunenori Kondo, Kenji Omae, Toshio Takagi, Jumpei Iizuka, Hirohito Kobayashi, Kazunari Tanabe
Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial
Oscar Arrieta, Graciela Cruz-Rico, Enrique Soto-Perez-de-Celis, Laura-Alejandra Ramírez-Tirado, Enrique Caballe-Perez, Jorge-Negueb Martínez-Hernández, Ivan Martinez-Alvarez, Giovanny Soca-Chafre, Eleazar Omar Macedo-Pérez, Horacio Astudillo-de la Vega
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
Anne von Mässenhausen, Mario Deng, Hannah Billig, Angela Queisser, Wenzel Vogel, Glen Kristiansen, Andreas Schröck, Friedrich Bootz, Friederike Göke, Alina Franzen, Lynn Heasley, Jutta Kirfel, Johannes Brägelmann, Sven Perner
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)
John D. Hainsworth, James A. Reeves, Joseph R. Mace, Edward J. Crane, Oday Hamid, John R. Stille, Amy Flynt, Stephanie Roberson, John Polzer, Edward R. Arrowsmith
Combinatorial Study of a Novel Poly (ADP-ribose) Polymerase Inhibitor and an HDAC Inhibitor, SAHA, in Leukemic Cell Lines
Mahesh Hegde, Kempegowda Mantelingu, Monica Pandey, Chottanahalli S. Pavankumar, Kanchugarakoppal S. Rangappa, Sathees C. Raghavan
Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of Everolimus
Marianne Pavel, Nicole Unger, Ivan Borbath, Sergio Ricci, Tsann-Long Hwang, Thomas Brechenmacher, Jinhee Park, Fabian Herbst, Jennifer L. Beaumont, Oliver Bechter
Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast Cancer
Srividya Vaidyanathan, Pulari U. Thangavelu, Pascal H. G. Duijf
Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer
H. Pluchart, E. Jacquet, D. Charlety, B. Allenet, P. Bedouch, M. Mousseau